These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5131535)

  • 1. The laboratory control of intravenous heparin therapy.
    Davies DW
    Med J Aust; 1971 Nov; 2(20):1001-5. PubMed ID: 5131535
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience with a thrombin clotting time assay for measuring heparin activity.
    Penner JA
    Am J Clin Pathol; 1974 May; 61(5):645-53. PubMed ID: 4827049
    [No Abstract]   [Full Text] [Related]  

  • 3. COAGULATION STUDIES IN EXTRACORPOREAL CIRCULATION.
    DYBKJAER E; BERG E; KISSMEYER-NIELSEN F
    Acta Chir Scand; 1964 Oct; 128():350-61. PubMed ID: 14211290
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring heparin therapy with the activated partial thromboplastin time.
    Stuart RK; Michel A
    Can Med Assoc J; 1971 Mar; 104(5):385-8. PubMed ID: 5557913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [BLOOD COAGULATION CHANGES AND THEIR RELATION TO THE EFFECT OF DRUGS IN HYPERTENSION].
    URBANIUK KG
    Kardiologiia; 1964; 4():45-8. PubMed ID: 14203916
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the BART test (a modification of the whole-blood activated recalcification time test) as a means of monitoring heparin therapy.
    Reno WJ; Rotman M; Grumbine FC; Dennis LH; Mohler ER
    Am J Clin Pathol; 1974 Jan; 61(1):78-84. PubMed ID: 4809149
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficiency and limits of blood coagulation tests].
    Róka L
    Internist (Berl); 1973 Apr; 14(4):149-53. PubMed ID: 4577209
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of a single-channel photo-optical clot-timing instrument.
    Weisbrot IM; Waldner DK
    Am J Clin Pathol; 1977 Sep; 68(3):361-7. PubMed ID: 900070
    [No Abstract]   [Full Text] [Related]  

  • 9. The activated partial thromboplastin time as a monitor of heparin therapy: a warning.
    Makary AZ; Waterbury L
    Johns Hopkins Med J; 1977 Jun; 140(6):311-5. PubMed ID: 864903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-enhanced inhibitors during reversible disseminated intravascular coagulation.
    Marbet GA; Griffith MJ; Roberts HR
    Scand J Clin Lab Invest Suppl; 1985; 178():95-8. PubMed ID: 3867125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential coagulation studies in purpura fulminans.
    Antley RM; McMillan CW
    N Engl J Med; 1967 Jun; 276(23):1287-90. PubMed ID: 6024349
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin therapy.
    Raich PC; Hahn MF; Korst DR
    Am Fam Physician; 1974 Sep; 10(3):163-8. PubMed ID: 4413661
    [No Abstract]   [Full Text] [Related]  

  • 13. [Parietal thromboplastin time, thromboplastin time fibrinogen, thrombin time and thrombocyte count in healthy and sick newborn infants].
    Göbel U; Riech P
    Monatsschr Kinderheilkd (1902); 1972 Dec; 120(12):484-8. PubMed ID: 4646962
    [No Abstract]   [Full Text] [Related]  

  • 14. EFFECT OF ANIMAL AND VEGETABLE FATS ON BLOOD COAGULATION IN HYPERTENSION PATIENTS.
    ALFEROVA LN
    Fed Proc Transl Suppl; 1963; 22():1143-6. PubMed ID: 14079320
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of heparin therapy: Controlled prospective trial.
    Salzman EW; Deykin D; Shapiro RM; Rosenberg R
    N Engl J Med; 1975 May; 292(20):1046-50. PubMed ID: 1091856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of a complex mixture of plasma proteins with heparin on the anticoagulation and fibrinolytic activity of the blood plasma in animals following intravenous administration of tissue thromboplastin].
    Pastorova VE
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jun; 74(6):814-9. PubMed ID: 3181520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin times and clottable fibrinogen determination on an automated coagulation laboratory (ACL-810).
    Castillo JB; Farag AM; Mammen EF; Sachs RJ
    Thromb Res; 1989 Jul; 55(2):213-9. PubMed ID: 2781525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activated thromboplastin time, plasma heparin and plasma fibrinogen using the Fibrintimer 10].
    Khayat MC; Laforet F; Khayat A; Derlon A; Lequerrec A; Thomas M
    Ann Biol Clin (Paris); 1988; 46(8):696-700. PubMed ID: 3218791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin treatment in thrombin-induced disseminated intravascular coagulation in the baboon.
    du Toit HJ; Coetzee AR; Chalton DO
    Crit Care Med; 1991 Sep; 19(9):1195-200. PubMed ID: 1884620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INFLUENCE OF TRAUMA AND HEMOLYSIS ON HEMORRHAGIC SHOCK IN DOGS.
    HARDAWAY RM; JOHNSON DG; ELOVITZ MJ; HOUCHIN DN; JENKINS EB; BURNS JW; JACKSON DR
    J Trauma; 1964 Sep; 4():624-41. PubMed ID: 14208788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.